A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...
News Medical on MSN3d
Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation
Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...
mskcc.org3d
Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure
MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...
Targeted Oncology6d
LYT-200 Gains FDA Fast Track Status in Acute Myeloid Leukemia
LYT-200 now has gained fast track designation from the FDA in acute myeloid leukemia in addition to its prior designation for ...
Science Daily8d
Leukemia News
Now researchers explain why, by identifying specific changes in blood cells of people with Down ... Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17 ...
The American Journal of Managed Care2d
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...
eLife4d
Early and delayed STAT1-dependent responses drive local trained immunity of macrophages in the spleen
In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.
Medscape7d
To Combat Leukemia, Researchers Harness CD37
Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.